Myriad Genetics (MYGN) Net Cash Flow: 2009-2025
Historic Net Cash Flow for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to $71.1 million.
- Myriad Genetics' Net Cash Flow rose 1294.12% to $71.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year increase of 84.43%. This contributed to the annual value of -$28.0 million for FY2024, which is 137.89% down from last year.
- As of Q3 2025, Myriad Genetics' Net Cash Flow stood at $71.1 million, which was up 497.21% from -$17.9 million recorded in Q2 2025.
- Myriad Genetics' Net Cash Flow's 5-year high stood at $177.2 million during Q3 2021, with a 5-year trough of -$92.6 million in Q1 2022.
- In the last 3 years, Myriad Genetics' Net Cash Flow had a median value of -$1.4 million in 2024 and averaged $8.0 million.
- Examining YoY changes over the last 5 years, Myriad Genetics' Net Cash Flow showed a top increase of 1,294.12% in 2025 and a maximum decrease of 1,178.57% in 2025.
- Quarterly analysis of 5 years shows Myriad Genetics' Net Cash Flow stood at -$36.5 million in 2021, then fell by 23.29% to -$45.0 million in 2022, then soared by 222.67% to $55.2 million in 2023, then plummeted by 94.93% to $2.8 million in 2024, then spiked by 1,294.12% to $71.1 million in 2025.
- Its Net Cash Flow was $71.1 million in Q3 2025, compared to -$17.9 million in Q2 2025 and -$11.0 million in Q1 2025.